ANTIVIRAL THERAPEUTIC AGENT Russian patent published in 2009 - IPC C07C235/28 C07C235/76 C07C237/22 C07C251/38 C07D209/20 A61K31/195 A61K31/216 A61K31/405 A61P31/12 A61P1/16 

FIELD: medicine.

SUBSTANCE: medical product against hepatitis C virus contains the bond presented by the following general formula (I) or its pharmaceutically comprehensible salt, and also to bond of the general formula (I) and to intermediate bond. In the general formula (I) A represents phenyl group replaced-OH, or 3-indolyl group; X represents atom of hydrogen, linear or branched out alkyl group containing 1-8 atoms of carbon, linear or branched out alkenyl the group containing 2-8 atoms of carbon, either linear or branched out alkynil group containing 2-8 atoms of carbon; B represents atom of hydrogen, hydroxylic group, oxogroup, =N-OH or =N-OR⁶; R⁶ represents linear or branched out alkyl group containing 1-8 atoms of carbon (which can be replaced by an amino group which can be mono-or disubstituted linear or branched out alkyl group containing 1-4 atoms of carbon); D represents atom of hydrogen or hydroxylic group; communication E represents simple communication or double communication; R¹, R² and R³ can be identical or various, and everyone represents hydroxylic group, an amino group (which can be mono-or disubstituted linear or branched out alkyl group containing 1-4 atoms of carbon) or -OZ; and Z represents linear or branched out alkyl group containing 1-4 atoms of carbon.

EFFECT: rising of efficiency of an agent and a way of treatment.

18 cl, 19 ex